ClinicalTrials.govpublic full text
Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
menopause, atherosclerosis, cardiovascular diseases, estrogen replacement therapy, randomized controlled trial, hormone therapy, vasomotor symptoms, quality of life, endothelium, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 880472
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.